Literature DB >> 30320664

Intracellular Localization of Microbial Transglutaminase and Its Influence on the Transport of Gliadin in Enterocytes.

Sebastian Stricker1, Jan de Laffolie1, Silvia Rudloff1,2, Lars Komorowski3, Klaus-Peter Zimmer1.   

Abstract

OBJECTIVE: Celiac disease (CD) is a systemic inflammatory disorder, characterized by the destruction of duodenal epithelium. The CD8 T cells involved are associated with cross-presentation. In addition to other factors, the rising prevalence of CD might be induced by microbial transglutaminase (mTG) an enzyme frequently used in food production that shares enzymatic and antigenic properties of tissue transglutaminase (TG2), the autoantigen in CD. We hypothesized that mTG and gliadin are transported into the endoplasmic reticulum (ER), indicating cross-presentation of both antigens.
METHODS: Apical incubation of duodenal biopsies from CD and control patients was performed with mTG alone or with mTG and simultaneously with Frazer's fraction. Evaluation was carried out by immunofluorescence and electron microscopy.
RESULTS: Approximately 6% to 9% of the intracellular mTG and gliadin were transported to the ER of enterocytes. RACE cells (Rapid uptake of Antigen into the Cytosol of Enterocytes) displayed an enhanced antigen uptake into a dilated ER. mTG strongly localized at the basolateral membrane and the lamina propria.
CONCLUSIONS: mTG and gliadin are transported to the ER of enterocytes and to a greater extent to the ER of RACE cells, suggesting cross-presentation of exogenous antigens. The strong localization of mTG at the basolateral membrane and the lamina propria may also indicate a potential antigenic interaction with cells of the immune system. Since mTG may not only been taken up with food stuffs but could also be released by bacteria within the intestinal microbiota, further investigations are needed regarding the role of mTG in CD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30320664     DOI: 10.1097/MPG.0000000000002171

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  7 in total

1.  Antibodies against neo-epitope of microbial and human transglutaminase complexes as biomarkers of childhood celiac disease.

Authors:  D Agardh; T Matthias; P Wusterhausen; S Neidhöfer; A Heller; A Lerner
Journal:  Clin Exp Immunol       Date:  2019-11-11       Impact factor: 4.330

2.  Tissue Transglutaminase but Not Microbial Transglutaminase Is Inhibited by Exogenous Oxidative Substances in Celiac Disease.

Authors:  Sebastian Stricker; Silvia Rudloff; Jan De Laffolie; Klaus-Peter Zimmer
Journal:  Int J Mol Sci       Date:  2022-02-17       Impact factor: 5.923

Review 3.  Type 2 Transglutaminase in Coeliac Disease: A Key Player in Pathogenesis, Diagnosis and Therapy.

Authors:  Gaetana Paolella; Silvia Sposito; Antonio Massimiliano Romanelli; Ivana Caputo
Journal:  Int J Mol Sci       Date:  2022-07-06       Impact factor: 6.208

4.  Microbial transglutaminase should be considered as an environmental inducer of celiac disease.

Authors:  Aaron Lerner; Torsten Matthias
Journal:  World J Clin Cases       Date:  2019-11-26       Impact factor: 1.337

5.  The temperature and pH repertoire of the transglutaminase family is expanding.

Authors:  Aaron Lerner; Ajay Ramesh; Torsten Matthias
Journal:  FEBS Open Bio       Date:  2020-04       Impact factor: 2.693

Review 6.  Processed Food Additive Microbial Transglutaminase and Its Cross-Linked Gliadin Complexes Are Potential Public Health Concerns in Celiac Disease.

Authors:  Aaron Lerner; Torsten Matthias
Journal:  Int J Mol Sci       Date:  2020-02-08       Impact factor: 5.923

Review 7.  "Let Food Be Thy Medicine": Gluten and Potential Role in Neurodegeneration.

Authors:  Aaron Lerner; Carina Benzvi
Journal:  Cells       Date:  2021-03-30       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.